Literature DB >> 18320153

[Sepsis therapy: present guidelines and their application].

F M Brunkhorst1, K Reinhart.   

Abstract

Severe sepsis and septic shock have an increasing incidence and unchanged high mortality. Early diagnosis is necessary to slow the progression of organ dysfunction and improve outcome. Early administration of broad-spectrum antimicrobial therapy, early and aggressive hemodynamic therapy, and surgical source control are the most promising therapeutic approaches. Norepinephrine is the first choice as a vasopressor. Starches for volume resuscitation, intensive insulin therapy (aiming at 80-110 mg/dl), and low-dose hydrocortisone are not recommended outside randomized trials. Recombinant activated protein C is one choice for certain patients. The German Sepsis Competence Network (SepNet) is currently investigating other open questions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18320153     DOI: 10.1007/s00104-008-1486-x

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  30 in total

1.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.

Authors:  R Bellomo; M Chapman; S Finfer; K Hickling; J Myburgh
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

Review 2.  Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis.

Authors:  Djillali Annane; Eric Bellissant; Pierre Edouard Bollaert; Josef Briegel; Didier Keh; Yizhak Kupfer
Journal:  BMJ       Date:  2004-08-02

3.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

Authors:  B L Warren; A Eid; P Singer; S S Pillay; P Carl; I Novak; P Chalupa; A Atherstone; I Pénzes; A Kübler; S Knaub; H O Keinecke; H Heinrichs; F Schindel; M Juers; R C Bone; S M Opal
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

Review 4.  Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient.

Authors:  Daren K Heyland; Rupinder Dhaliwal; Ulrich Suchner; Mette M Berger
Journal:  Intensive Care Med       Date:  2004-12-17       Impact factor: 17.440

5.  Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study.

Authors:  B Levy; P E Bollaert; C Charpentier; L Nace; G Audibert; P Bauer; P Nabet; A Larcan
Journal:  Intensive Care Med       Date:  1997-03       Impact factor: 17.440

6.  Measurements of serum free cortisol in critically ill patients.

Authors:  Amir H Hamrahian; Tawakalitu S Oseni; Baha M Arafah
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

7.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

Review 8.  Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review.

Authors:  Julie Pildal; Peter C Gøtzsche
Journal:  Clin Infect Dis       Date:  2004-06-01       Impact factor: 9.079

9.  Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.

Authors:  Djillali Annane; Philippe Vignon; Alain Renault; Pierre-Edouard Bollaert; Claire Charpentier; Claude Martin; Gilles Troché; Jean-Damien Ricard; Gérard Nitenberg; Laurent Papazian; Elie Azoulay; Eric Bellissant
Journal:  Lancet       Date:  2007-08-25       Impact factor: 79.321

10.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

View more
  1 in total

1.  Protective Effects of Silymarin Against D-Gal/LPS-Induced Organ Damage and Inflammation in Mice.

Authors:  Xin Zhao; Haoxiang Wang; Yue Yang; Yuting Gou; Zhiying Wang; Dingyi Yang; Chong Li
Journal:  Drug Des Devel Ther       Date:  2021-05-04       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.